[Congenital cerebral hypomyelination---Pelizaeus-Merzbacher disease and associated disorders]

Ken Inoue1, Akiko Iwaki, Kenji Kurosawa

  • 1Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo. kinoue@ncnp.go.jp

Insights

New research introduces a classification and diagnostic criteria for congenital cerebral hypomyelination disorders, aiding in the diagnosis of these rare genetic conditions.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Congenital cerebral hypomyelination is a group of genetic disorders affecting cerebral white matter myelination.
  • Pelizaeus-Merzbacher disease (PMD) is a known example, but other related disorders lacked classification.
  • Recent gene discoveries necessitate updated diagnostic approaches.

Purpose of the Study:

  • To review recent findings on congenital cerebral hypomyelination.
  • To establish a novel disease classification and diagnostic criteria for these disorders.
  • To provide clinical guidance through flow charts.

Main Methods:

  • Literature review of recent findings in congenital cerebral hypomyelination.
  • Synthesis of genetic and clinical data for 11 distinct disease entities.
  • Development of a novel classification system and diagnostic flow charts.

Main Results:

  • Identification and review of 11 distinct congenital cerebral hypomyelination diseases.
  • Establishment of a novel classification system for these disorders.
  • Creation of diagnostic criteria and flow charts to aid clinical assessment.

Conclusions:

  • A new classification and diagnostic criteria are crucial for congenital cerebral hypomyelination disorders.
  • The proposed system aids in differentiating and diagnosing these rare genetic conditions.
  • This framework supports improved clinical management and research.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...